Lajos Mátyás

1.5k total citations
6 papers, 266 citations indexed

About

Lajos Mátyás is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Lajos Mátyás has authored 6 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Internal Medicine. Recurrent topics in Lajos Mátyás's work include Peripheral Artery Disease Management (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Lajos Mátyás is often cited by papers focused on Peripheral Artery Disease Management (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Lajos Mátyás collaborates with scholars based in Hungary, Germany and Canada. Lajos Mátyás's co-authors include Rupert Bauersachs, P. Prandoni, German Sokurenko, Z Boda, Saskia Middeldorp, Patrick Mismetti, Benjamin Brenner, Silvy Laporte, Lars Norgren and Arkadiusz Jawień and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and Journal of Thrombosis and Haemostasis.

In The Last Decade

Lajos Mátyás

6 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lajos Mátyás Hungary 6 200 178 117 69 30 6 266
Hosam El Sayed United States 4 187 0.9× 173 1.0× 32 0.3× 139 2.0× 11 0.4× 7 249
Huisman Mv Netherlands 5 143 0.7× 65 0.4× 65 0.6× 61 0.9× 86 2.9× 17 200
N. Wilson United Kingdom 7 105 0.5× 100 0.6× 117 1.0× 7 0.1× 91 3.0× 10 216
Slobodan Antov North Macedonia 8 38 0.2× 53 0.3× 60 0.5× 29 0.4× 38 1.3× 16 169
AA Castro Brazil 3 63 0.3× 105 0.6× 93 0.8× 10 0.1× 23 0.8× 3 194
Nilo Mitsuru Izukawa Brazil 8 214 1.1× 239 1.3× 17 0.1× 110 1.6× 2 0.1× 41 289
François-Xavier Lapébie France 7 45 0.2× 60 0.3× 27 0.2× 12 0.2× 7 0.2× 23 149
Alan J. Merritt United States 6 94 0.5× 232 1.3× 162 1.4× 51 0.7× 6 0.2× 9 340
Piotr Szopiński Poland 9 36 0.2× 111 0.6× 50 0.4× 11 0.2× 7 0.2× 26 236
Ilham Benzidia France 5 50 0.3× 18 0.1× 34 0.3× 19 0.3× 9 0.3× 12 89

Countries citing papers authored by Lajos Mátyás

Since Specialization
Citations

This map shows the geographic impact of Lajos Mátyás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lajos Mátyás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lajos Mátyás more than expected).

Fields of papers citing papers by Lajos Mátyás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lajos Mátyás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lajos Mátyás. The network helps show where Lajos Mátyás may publish in the future.

Co-authorship network of co-authors of Lajos Mátyás

This figure shows the co-authorship network connecting the top 25 collaborators of Lajos Mátyás. A scholar is included among the top collaborators of Lajos Mátyás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lajos Mátyás. Lajos Mátyás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
Krantz, Mori J., Sebastian Debus, Judith Hsia, et al.. (2021). Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. European Heart Journal. 42(39). 4040–4048. 14 indexed citations
3.
Prandoni, P., Patrick Mismetti, Rupert Bauersachs, et al.. (2010). Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs. New England Journal of Medicine. 363(13). 1222–1232. 195 indexed citations
4.
Mátyás, Lajos, Miles G. Berry, G. Menyhei, et al.. (2008). The Safety and Efficacy of a Paclitaxel-eluting Wrap for Preventing Peripheral Bypass Graft Stenosis: A 2-Year Controlled Randomized Prospective Clinical Study. European Journal of Vascular and Endovascular Surgery. 35(6). 715–722. 12 indexed citations
5.
Norgren, Lars, et al.. (2006). Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication. A Phase II European study. Vascular Medicine. 11(2). 75–83. 23 indexed citations
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hosam El Sayed Breakdown of academic impact, for papers by Huisman Mv Breakdown of academic impact, for papers by N. Wilson Breakdown of academic impact, for papers by Slobodan Antov Breakdown of academic impact, for papers by AA Castro Breakdown of academic impact, for papers by Nilo Mitsuru Izukawa Breakdown of academic impact, for papers by François-Xavier Lapébie Breakdown of academic impact, for papers by Alan J. Merritt Breakdown of academic impact, for papers by Piotr Szopiński Breakdown of academic impact, for papers by Ilham Benzidia
Rankless by CCL
2026